More articles from Translational Science

You have access
Strategies to Inhibit ABCB1- and ABCG2-Mediated Efflux Transport of Erlotinib at the Blood–Brain Barrier: A PET Study on Nonhuman Primates
Nicolas Tournier, Sebastien Goutal, Sylvain Auvity, Alexander Traxl, Severin Mairinger, Thomas Wanek, Ourkia-Badia Helal, Irène Buvat, Michael Soussan, Fabien Caillé and Oliver Langer

Journal of Nuclear Medicine January 1, 2017, 58 (1) 117-122; DOI: https://doi.org/10.2967/jnumed.116.178665
You have access
⁶⁸Ga-PSMA-11 PET Imaging of Response to Androgen Receptor Inhibition: First Human Experience
Thomas A. Hope, Charles Truillet, Eric C. Ehman, Ali Afshar-Oromieh, Rahul Aggarwal, Charles J. Ryan, Peter R. Carroll, Eric J. Small and Michael J. Evans

Journal of Nuclear Medicine January 1, 2017, 58 (1) 81-84; DOI: https://doi.org/10.2967/jnumed.116.181800
You have access
Red Marrow–Absorbed Dose for Non-Hodgkin Lymphoma Patients Treated with ¹⁷⁷Lu-Lilotomab Satetraxetan, a Novel Anti-CD37 Antibody–Radionuclide Conjugate
Johan Blakkisrud, Ayca Løndalen, Jostein Dahle, Simon Turner, Harald Holte, Arne Kolstad and Caroline Stokke

Journal of Nuclear Medicine January 1, 2017, 58 (1) 55-61; DOI: https://doi.org/10.2967/jnumed.116.180471
You have access
Tumor-Absorbed Dose for Non-Hodgkin Lymphoma Patients Treated with the Anti-CD37 Antibody Radionuclide Conjugate ¹⁷⁷Lu-Lilotomab Satetraxetan
Johan Blakkisrud, Ayca Løndalen, Anne C.T. Martinsen, Jostein Dahle, Jon E. Holtedahl, Tore Bach-Gansmo, Harald Holte, Arne Kolstad and Caroline Stokke

Journal of Nuclear Medicine January 1, 2017, 58 (1) 48-54; DOI: https://doi.org/10.2967/jnumed.116.173922

Main menu

User menu

Search

More articles from Translational Science